Home/Spirair/Paul Praino

PP

Paul Praino

VP of Sales

Therapeutic Areas

Respiratory Otolaryngology

Spirair Pipeline

Drug	Indication	Phase
SeptAlign	Minor Nasal Septal Deviation (NSD)	Approved
TurbAlign	Turbinate Hypertrophy/Medialization	Pre-commercial

Leadership Team at Spirair

Chief Executive Officer

James Kintzing, PhD

Co-founder & Chief Technology Officer

Brandon McCutcheon, MD

Co-founder & Chief Medical Officer

Vice President, Clinical, Quality & Regulatory

Executive Vice President, R&D and Operations

View full Spirair profile